Cargando…

The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population

OBJECTIVE: The prevalence of polycystic ovary syndrome (PCOS) in the Qatari population is unknown and hence the estimated impact on the local population cannot be determined. The purpose of this study was to estimate the prevalence and metabolic features of PCOS among Qatari women. DESIGN: Cross sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dargham, Soha R., Ahmed, Lina, Kilpatrick, Eric S., Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517053/ https://www.ncbi.nlm.nih.gov/pubmed/28723965 http://dx.doi.org/10.1371/journal.pone.0181467

Ejemplares similares

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
por: Dargham, Soha R., et al.
Publicado: (2018)

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
por: Al-Hail, Noora, et al.
Publicado: (2019)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
por: Butler, Alexandra E., et al.
Publicado: (2020)

Association of Differing Qatari Genotypes with Vitamin D Metabolites
por: Dakroury, Youssra, et al.
Publicado: (2020)

Qatari Genotype May Contribute to Complications in Type 2 Diabetes
por: Dakroury, Youssra, et al.
Publicado: (2020)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
por: Cho, Li-Wei, et al.
Publicado: (2017)

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
por: Dawson, Alison J., et al.
Publicado: (2017)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population
por: Al-Dabhani, K, et al.
Publicado: (2017)

Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
por: Kahal, Hassan, et al.
Publicado: (2015)

Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome
por: Kumar, Amar Nagesh, et al.
Publicado: (2016)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar
por: Humphrey, John M., et al.
Publicado: (2019)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
por: Głuszak, Olgierd, et al.
Publicado: (2012)

Metabolic effects of polycystic ovary syndrome in adolescents
por: Han, Yejin, et al.
Publicado: (2015)

Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome
por: Blumenfeld, Zeev, et al.
Publicado: (2016)

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
por: Jabczyk, Marzena, et al.
Publicado: (2023)

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
por: Yu, Jin, et al.
Publicado: (2023)

Clinical and metabolic characteristics of endometrial lesions in polycystic ovary syndrome at reproductive age
por: Zhong⋅, Xiaozhu, et al.
Publicado: (2023)

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran
por: Zahiri, Ziba, et al.
Publicado: (2016)

Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome
por: Mir, Fayaz Ahmad, et al.
Publicado: (2022)

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
por: Javed, Zeeshan, et al.
Publicado: (2019)

Exome Sequencing of Only Seven Qataris Identifies Potentially Deleterious Variants in the Qatari Population
por: Rodriguez-Flores, Juan L., et al.
Publicado: (2012)

Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
por: Diboun, Ilhame, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qgrl15mquurk9h827593tc226